As of May 30, 2026, Wave Life Sciences's top three insider holders are Capital Management, L.P. Ra (Director, 26.98Mn shares), Plc Gsk (TenPercentOwner, 18.25Mn shares), Capital Management, L.P. Ra (Director, 18.20Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Plc Gsk | - | 0 | 18,245,691 | 15 Dec, 2025 |
| Mark Corrigan | - | 28,815 | 0 | 10 Dec, 2025 |
| Christian O Henry | - | 12,700 | 0 | 10 Dec, 2025 |
| Capital Management, L.P. Ra | - | 0 | 26,975,505 | 30 Mar, 2026 |
| Adrian Rawcliffe | - | 12,700 | 0 | 10 Dec, 2025 |
| Gregory L. Verdine | - | 275,217 | 0 | 10 Dec, 2025 |
| Heidi L Wagner | - | 44,930 | 0 | 10 Dec, 2025 |
| Chandra Vargeese | Chief Technology Officer | 408,246 | 0 | 11 Feb, 2026 |
| Chris Francis | - | 61,867 | 0 | 27 Feb, 2026 |
| Paul Bolno | President And Ceo | 275,520 | 0 | 11 Feb, 2026 |
| Kyle Moran | Chief Financial Officer | 134,385 | 0 | 11 Feb, 2026 |
| Ken Takanashi | - | 0 | 9,606,408 | 26 Mar, 2026 |
| Michael A. Panzara | Chief Medical Officer | 109,103 | 0 | 06 May, 2022 |
| Aik Na Tan | - | 25,400 | 0 | 10 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Mar, 2026 | Capital Management, L.P. Ra | Ordinary Shares | A | 4,954,558 | $6.06 | 23,157,567 | I | P |
| 26 Mar, 2026 | Capital Management, L.P. Ra | Ordinary Shares | A | 351,224 | $6.38 | 23,508,791 | I | P |
| 27 Mar, 2026 | Capital Management, L.P. Ra | Ordinary Shares | A | 2,495,623 | $6.43 | 26,004,414 | I | P |
| 30 Mar, 2026 | Capital Management, L.P. Ra | Ordinary Shares | A | 971,091 | $6.50 | 26,975,505 | I | P |
| 23 Mar, 2026 | Ken Takanashi | Ordinary Shares | A | 3,901,348 | $0.00 | 9,606,408 | I | C |
| 23 Mar, 2026 | Ken Takanashi | Series A Preferred Shares | D | 3,901,348 | $0.00 | 0 | I | C |
| 26 Feb, 2026 | Chris Francis | Ordinary Shares | A | 17,900 | $3.87 | 79,767 | D | M |
| 26 Feb, 2026 | Chris Francis | Ordinary Shares | D | 17,900 | $15.09 | 61,867 | D | S |
| 26 Feb, 2026 | Chris Francis | Ordinary Shares | A | 15,294 | $4.75 | 77,161 | D | M |
| 26 Feb, 2026 | Chris Francis | Ordinary Shares | D | 15,294 | $15.00 | 61,867 | D | S |
| 26 Feb, 2026 | Chris Francis | Share Option (right to buy) | D | 17,900 | $0.00 | 143,200 | D | M |
| 26 Feb, 2026 | Chris Francis | Share Option (right to buy) | D | 15,294 | $0.00 | 61,175 | D | M |
| 05 Feb, 2026 | Kyle Moran | Ordinary Shares | A | 45,625 | $0.00 | 137,973 | D | A |
| 05 Feb, 2026 | Chris Francis | Ordinary Shares | A | 38,750 | $0.00 | 63,750 | D | A |
| 05 Feb, 2026 | Chandra Vargeese | Ordinary Shares | A | 45,625 | $0.00 | 411,474 | D | A |
| 05 Feb, 2026 | Paul Bolno | Ordinary Shares | A | 165,000 | $0.00 | 286,000 | D | A |
| 09 Feb, 2026 | Chris Francis | Ordinary Shares | D | 1,883 | $13.45 | 61,867 | D | S |
| 09 Feb, 2026 | Kyle Moran | Ordinary Shares | D | 3,588 | $13.45 | 134,385 | D | S |
| 09 Feb, 2026 | Paul Bolno | Ordinary Shares | D | 10,480 | $13.45 | 275,520 | D | S |
| 09 Feb, 2026 | Chandra Vargeese | Ordinary Shares | D | 3,228 | $13.45 | 408,246 | D | S |